Head of Operations
Head of Operations, Oxford Respiratory Trials Unit
I have worked at the Oxford Respiratory Trials Unit since 2009. My current role involves managing a team of research professionals to deliver the trials being run through the unit. I ensure that appropriate funding, systems and resources are in place to ensure trials are delivered on time and within budget, and meet the appropriate clinical trial and research governance requirements.
Prior to joining ORTU I worked in the Pharmaceutical/Biotech Industry for over 10 years. I have worked across a range of therapeutic areas and phases of trials in various roles including trial management and monitoring, data management, feasibility and strategy development.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Butler CC. et al, (2023), The Lancet, 401, 281 - 293
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial
Psallidas I. et al, (2022), The Lancet Respiratory Medicine, 10, 139 - 148
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation
Asciak R. et al, (2021), Frontiers in Oncology, 11
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments
Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study
Corcoran JP. et al, (2020), European Respiratory Journal, 56, 2000130 - 2000130